|
|
|
| Setting the Standard for a Simplified Path to Regulatory Compliance | Adhering to the latest regulatory requirements is critical to simplifying registrations and interactions with authorities. Set the standard in simplified commercialization with testing and validation services, along with expert regulatory support and products and services backed by rigorous quality-assurance processes. Reduce risk with sterile, single-use solutions that maximize closed, aseptic processing. Protect against contamination using serum- and xeno-free cell culture media and reagents. Learn more. |
|
|
|
|
By Life Science Connect Editorial Staff | By employing flexible and sustainable design strategies and best practices, combined with contingency planning, cell and gene therapy companies can make building their own facilities a reality. |
|
|
|
Listen to tremendous detail around the challenges facing autologous cell therapy manufacturing, from the need for automation in manufacturing to the sourcing of tissue from a specific patient. |
|
|
|
|
| Cell Line Development For High-Titer Lentivirus Vector Production | Case Study | By Hairui Yang, Han Gao, Houliang Wei, Qinrui You, Guodong Jia, and Weiran Shen, OBiO Tech | Explore a groundbreaking method to significantly enhance LV vector yield using engineered HEK293T cells. This method sets the stage for enhancing the efficiency and scalability of LV vector production. |
|
|
| Development And Optimization Of Suspension-Adapted 293T Cell Line | White Paper | By Joshua Gutierrez, Chakrapani Tripathi, Ph.D., Sergey Zolov, Ph.D., Frank Luh., and Venkatesh Natarajan, Ph.D., Theragent | Understand how an adapted cell line can reduce costs and improve scalability in the production of lentiviral vectors for CGTs and examine its potential to produce GMP-grade lentiviral vectors. |
|
|
|
| Accelerating Rare Disease Treatments From Concept To Cure | Webinar | FUJIFILM Diosynth Biotechnologies | Access a thorough investigation that delves into the critical aspects of expediting curative therapies, with a focus on the strategic role that CDMOs can play in this transformative journey. |
|
|
|
|
|
| Connect With Cell & Gene: |
|
|
|
